Osteoarthritis and degenerative joint disease: Local treatment options update

Acta Biomedica

Volumn 81, Issue 2, 2010, Pages 94-100

  Palmieri, Beniamino ^a   Lodi, Daniele ^a   Capone, Stefania ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Glucocorticoids; Hyaluronic acid; Intra articular injection; Joint disease; Osteoarthritis

Indexed keywords

BUPIVACAINE; DEXAMETHASONE; DEXAMETHASONE 21 PALMITATE; ETANERCEPT; GLUCOCORTICOID; HYALURONIC ACID; INDOPROFEN; INFLIXIMAB; LIDOCAINE; METALLOPROTEINASE; METHOTREXATE; METHYLPREDNISOLONE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLBUTAZONE; PLACEBO; RIMEXOLONE; SEROTONIN ANTAGONIST; SOMATOSTATIN; STEROID; SUPEROXIDE DISMUTASE; TENOXICAM; TOPISTERON; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG; ANTIRHEUMATIC AGENT; VISCOSUPPLEMENT;

ABSENCE OF SIDE EFFECTS; ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE DEGENERATION; DACTYLITIS; DISEASE MODEL; DRUG ABSORPTION; DRUG EFFICACY; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG RECEPTOR BINDING; FUNCTIONAL STATUS; GASTROINTESTINAL SYMPTOM; HIP OSTEOARTHRITIS; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; KNEE OSTEOARTHRITIS; NONHUMAN; OSTEOARTHRITIS; PAIN; PROTECTION; PSORIATIC ARTHRITIS; REVIEW; RHEUMATOID ARTHRITIS; INTRAARTICULAR DRUG ADMINISTRATION;

ANTIRHEUMATIC AGENTS; GLUCOCORTICOIDS; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; OSTEOARTHRITIS; VISCOSUPPLEMENTS;

EID: 79952258225     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Svanovsky E. Physiology and pharmacology of hyaluronic acid. Ceska Slov Fam 2007; 56 (6): 264-8.
2. Bastow ER, Byers S, Golub SB, Clarkin CE, Pitsillides AA, Fosang AJ. Hyaluronan synthesis and degradation in cartilage and bone. Cell Mol Life Sci 2008; 65 (3): 395-413.
3. Kiani C, Chen L, Wu YJ, Yee AJ, Yang BB. Structure and function of aggrecan. Cell Res 2002; 12 (1): 19-32.
4. Radaeva IF, Kostina GA, Zmievski AV. Hyaluronic acid: biological role, structure, synthesis, isolation, purification, and application (review). Prikl Biokhim Mikrobiol 1997; 33 (2): 133-7.
5. Shimizu M, Yasuda T, Nakagawa T, et al. Hyaluronan inhibits matrix metalloproteinase-1 production by rheumatoid synovial fibroblasts stimulated by proinflammatory cytokines. J Rheumatol 2003; 30 (6): 1164-72.
6. Waddell DD, Kolomytkin OV, Dunn S, Marino AA. Hyaluronan suppresses IL-1beta-induced metalloproteinase activity from synovial tissue. Clin Orthop Relat Res 2007; 465: 241-8.
7. Sezgin M, Demirel AC, Sezgin M, et al. Does hyaluronan affect inflammatory cytokines in knee osteoarthritis? Rheumatol Int 2005; 25 (4): 264-9.
8. Karatay S, Kiziltunc A, Yildirim K, Karanfil RC, Senel K. Effects of different hyaluronic acid products on synovial fluid levels of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in knee osteoarthritis. Ann Clin Lab Sci 2004; 34 (3): 330-5.
9. Ghosh P, Guidolin D. Potential mechanism of action of intrarticular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent? Semin Arthritis Rheum 2003; 32 (1): 10-37.
10. Gotoh S, Onaya J, Abe M, et al. Effects of the molecular weight of hyaluronic acid and its action mechanism on experimental joint pain in rats. Ann Rheum Dis 1993; 52 (11): 817-22.
11. Maneiro E, de Andres MC, Fernández-Sueiro JL, Galdo F, Blanco FJ. The biological action of hyaluronan on human osteoarthritic articular chondrocytes: the importance of molecular weight. Clin Exp Rheumatol 2004; 22 (3): 307-12.
12. Marson P, Pasero G, Punzi L, Zanchin G. On the main stages of the history of intra-articular therapy. Reumatismo 2007; 59 (3): 262-8.
13. Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G. Intraarticular corticosteroid for treatment of osteoarthritis of the knee (review). The Cochrane Library 2008; issue 2.
14. Fuchs S, Mönikes R, Wohlmeiner A, Heyse T. Intra-articular hyaluronic acid compared with corticoid injections for the treatment of rhizarthrosis. Osteoarth Cartil 2006; 14 (1): 82-8.
15. Migliore A, Tormenta S, Massafra U, et al. Intra-articular administration of Hylan G-F 20 in patients with symptomatic hip osteoarthritis: tolerability and effectiveness in a large cohort study in clinical practice. Curr Med Res Opin 2008; 24 (5): 1309-16.
16. Gerwin N, Hops C, Lucke A. Intraarticular drug delivery in osteoarthritis. Adv Drug Deliv Rev 2006; 58 (2): 226-42.
17. Ayral X. Injections in the treatment of osteoarthritis. Best Pract Res, Clin Rheumatol 2001; 15: 609-26.
18. Goldberg VM, Buckwalter JA. Hyaluronans in the treatment of osteoarthritis of the knee: evidence for diseasemodifying activity. Osteoarthr Cartil 2005; 13: 216-24.
19. Fachinformation Lipotalon. BPI Service GmbH, 2003.
20. Jones J, Pattrick M, Doherty S, Doherty M. Intra-articular glucocorticoids and other injection therapies. Osteoarthritis, 2003.
21. Papathanassiou NP. Intra-articular use of tenoxicam in degenerative osteoarthritis of the knee joint. J Int Med Res 1994; 22 (6): 332-7.
22. Oztuna V, Eskandari M, Bugdayci R, Kuyurtar F. Intra-articular injection of tenoxicam in osteoarthritic knee joints with effusion. Orthopedics 2007; 30 (12): 1039-42.
23. Egsmose C, Lund B, Bach Andersen R. Hip joint distension in osteoarthrosis. A triple-blind controlled study comparing the effect of intra-articular indoprofen with placebo. Scand J Rheumatol 1984; 13 (3): 238-42.
24. Fu P, Wu Y, Wu H, Li X, Qian Q, Zhu Y. Efficacy of intra-articular cocktail analgesic injection in total knee arthroplasty - a randomized controlled trial. Knee 2009; 16 (4): 280-4.
25. Fioravanti A, Govoni M, La Montagna G, et al. Somatostatin 14 and joint inflammation: evidence for intraarticular efficacy of prolonged administration in rheumatoid arthritis. Drugs Exp Clin Res 1995; 21 (3): 97-103.
26. Ciocci A, Coari G, Di Franco M, Di Novi MR, Mauceri MT. Intra-articular treatment with somatostatin 14 in rheumatoid arthritis. Clin Ter 1994; 145 (12): 463-7.
27. Russo S, Mangrella M, Vitagliano S, Russo P, Berrino L. Local administration of somatostatin in joint diseases in athletes. Minerva Med 1997; 88 (6): 265-70.
28. Coari G, Di Franco M, Iagnocco A, Di Novi MR, Mauceri MT, Ciocci A. Intra-articular somatostatin 14 reduces synovial thickness in rheumatoid arthritis: an ultrasonographic study. Int J Clin Pharmacol Res 1995; 15 (1): 27-32.
29. Alstergren P, Larsson PT, Kopp S. Successful treatment with multiple intra-articular injections of infliximab in a patient with psoriatic arthritis. Scand J Rheumatol 2008; 37 (2): 155-7.
30. Helliwell PS. Therapies for dactylitis in psoriatic arthritis. A systematic review. J Rheumatol 2006; 33 (7): 1439-41.
31. Schatteman L, Gyselbrecht L, De Clercq L, Mielants H. Treatment of refractory inflammatory monoarthritis in ankylosing spondylitis by intraarticular injection of infliximab. J Rheumatol 2006; 33 (9): 1912-3.
32. Bliddal H, Terslev L, Qvistgaard E, et al. Safety of intra-articular injection of etanercept in small-joint arthritis: an uncontrolled, pilot-study with independent imaging assessment. Joint Bone Spine 2006; 73 (6): 714-7.
33. Bliddal H, Terslev L, Qvistgaard E, et al. A randomized, controlled study of a single intra-articular injection of etanercept or glucocorticosteroids in patients with rheumatoid arthritis. Scand J Rheumatol 2006; 35 (5): 341-5.
34. Niehues T, Lankisch P. Recommendations for the use of methotrexate in juvenile idiopathic arthritis. Peadiatr Drugs 2006; 8 (6): 347-56.
35. Iagnocco A, Cerioni A, Coari G, Ossandon A, Masciangelo R, Valesini G. Intra-articular methotrexate in the treatment of rheumatoid arthritis and psoriatic arthritis: a clinical and sonographic study. Clin Rheumatol 2006; 25 (2): 159-63.
36. Gao IK, Leins C, Bohlen H, Heilig B, Lemmel EM. Inhibition of interleukin-8 synthesis by intraarticular methotrexate therapy in patients with rheumatoid arthritis. Z Rheumatol 1998; 57 (2): 95-100.
37. Theiler R, Brühlmann P. Overall tolerability and analgesic activity of intra-articular sodium hyaluronate in the treatment of knee osteoarthritis. Curr Med Resp Opinion 2005; 21 (11): 1727-33.
38. Castellacci E, Polieri T. Antalgic effect and clinical tolerability of hyaluronic acid in patients with degenerative disease of knee cartilage: an outpatient treatment survey. Drugs Exptl Clin Res 2004; 30 (2): 67-73.
39. Raman R, Dutta A, Day N, Sharma HK, Shaw CJ, Johnson GV. Efficacy of Hylan G-F 20 and Sodium Hyaluronate in the treatment of osteoarthritis of the knee - A prospectiverandomizedclinicaltrial. Knee 2008;15: 318-24.
40. Huskin JP, Vandekerckhove B, Delincé P, et al. Multicentre, prospective, open study to evaluate the safety and the efficacy of hylan G-F 20 in knee osteoarthritis in subjects presenting with pain following arthroscopic meniscectomy. Knee Surg Sports Traumatol Arthrsc 2008: 7.
41. Ulucay C, Altintaş F, Ugutmen E, Beksaç B. The use of arthroscopic debridement and viscosupplementation in knee osteoarthritis. Acta Orthop Traumatol Turc 2007; 41 (5): 337-42.
42. Karatosun V, Unver B, Gocen Z, Sen A. Comparison of two hyaluronan drugs in patients with advanced osteoarthritis of the knee. A prospective, randomized, doubleblind study with long term follow-up. Clin Exp Rheumatol 2005; 23 (2): 213-8.
43. Huang MH, Yang RC, Lee CL, Chen TW, Wang MC. Preliminary results of integrated therapy for patients with knee osteoarthritis. Arthritis Rheum 2005; 53 (6): 812-20.
44. Needle pathology. C.M.A. Journal. 1972.106:957.